Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.
about
Antimicrobial synergy between carprofen and doxycycline against methicillin-resistant Staphylococcus pseudintermedius ST71.High genotypic diversity among methicillin-resistant Staphylococcus pseudintermedius isolated from canine infections in DenmarkIn Vitro Antimicrobial Susceptibility of Staphylococcus pseudintermedius Isolates of Human and Animal Origin.Recommendations for approaches to meticillin-resistant staphylococcal infections of small animals: diagnosis, therapeutic considerations and preventative measures.: Clinical Consensus Guidelines of the World Association for Veterinary Dermatology.Carriage rate and antibiotic susceptibility of coagulase-positive staphylococci isolated from healthy dogs in Victoria, Australia.Evaluation of canine-specific minocycline and doxycycline susceptibility breakpoints for meticillin-resistant Staphylococcus pseudintermedius isolates from dogs.Pharmacokinetics of minocycline in domestic cats.A Monte Carlo pharmacokinetic/pharmacodynamic simulation to evaluate the efficacy of minocycline, tigecycline, moxifloxacin, and levofloxacin in the treatment of hospital-acquired pneumonia caused by Stenotrophomonas maltophilia.Considerations for using minocycline vs doxycycline for treatment of canine heartworm disease.Minocycline pharmacokinetics and pharmacodynamics in dogs: dosage recommendations for treatment of meticillin-resistant Staphylococcus pseudintermedius infections.Direct repeat unit (dru) typing and antimicrobial resistance of methicillin-resistant Staphylococcus pseudintermedius isolated from dogs in Atlantic Canada.Higher bioavailability of doxycycline in broiler chickens with a novel in-feed pharmaceutical formulation.The pharmacokinetic-pharmacodynamic modeling and cut-off values of tildipirosin against Haemophilus parasuis.En Route towards European Clinical Breakpoints for Veterinary Antimicrobial Susceptibility Testing: A Position Paper Explaining the VetCAST Approach.Comparative in vitro killing of canine strains of Staphylococcus pseudintermedius and Escherichia coli by cefovecin, cefazolin, doxycycline and pradofloxacin.
P2860
Q36061449-768D4E12-C43D-4518-826A-3EACAF10F21FQ36064321-93796EB6-F1EA-4F41-877B-D9E1672186AAQ36834743-443028C6-F7DE-4CCB-BD57-9D7D75083B3DQ39314333-02BD0FED-57B8-48B3-B916-83287669906AQ40470327-A2B28458-6112-4380-91E8-7EB247AA1472Q40690370-11E9FFEF-44F7-40DC-A3D7-E3889A1350BAQ41104042-F5723D51-AE02-4263-9069-58D7EB33EC4FQ41111507-4537A9F6-937C-4B1D-ADF2-0DFE1CFF23BEQ44877114-09A10B7B-8697-45E8-816B-9D0A224AF4FDQ46892886-8DAED426-922C-4BC8-9C00-8024CF56BE80Q47120528-CE556ABD-59F9-4428-86EF-40159CB7EBCAQ47315435-FDD6FA49-B411-40F3-89B6-38E0185CBC1CQ49210057-9C8EE261-4809-4F16-A529-5031F5D6A196Q49429759-89AEC830-A4E5-4827-8949-8A4E62133E14Q52863922-39A02FCF-B49C-4D4B-8087-DD2D782EE7BF
P2860
Pharmacodynamics of doxycycline and tetracycline against Staphylococcus pseudintermedius: proposal of canine-specific breakpoints for doxycycline.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Pharmacodynamics of doxycyclin ...... c breakpoints for doxycycline.
@en
type
label
Pharmacodynamics of doxycyclin ...... c breakpoints for doxycycline.
@en
prefLabel
Pharmacodynamics of doxycyclin ...... c breakpoints for doxycycline.
@en
P2860
P356
P1476
Pharmacodynamics of doxycyclin ...... c breakpoints for doxycycline.
@en
P2093
John Turnidge
Marit Gaastra Maaland
P2860
P304
P356
10.1128/JCM.01498-13
P407
P577
2013-08-21T00:00:00Z